Sea Mild Biotechnology Co., Ltd. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was TWD 131.324 million compared to TWD 77.263 million a year ago. Operating loss was TWD 15.887 million compared to TWD 43.695 million a year ago. Net loss was TWD 14.421 million compared to TWD 35.340 million a year ago. Basic loss per share was TWD 0.57 compared to TWD 1.44 a year ago.